SCHEMBL11035332

SCHEMBL11035332

CCOC(=O)OC1=C(C)Nc2cc[nH]c(=O)c2C1c1ccccc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 3/20 0.44
HSD17B10 Q99714 4/20 0.42
ACHE P22303 3/20 0.42
ALDH1A1 P00352 4/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
LMNA P02545 1/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10784001 0.87 ACHE (0.55) DHFRHSD17B10ACHEALDH1A1CYP2C9
SCHEMBL10502213 0.87 GAA (0.40) HSD17B10ALDH1A1CYP2C9CYP2C19MEN1
SCHEMBL10502995 0.87 TSHR (0.47) HSD17B10ALDH1A1CYP2C9CYP2C19MEN1
SCHEMBL10746130 0.84 ACHE (0.43) ACHE
SCHEMBL10503110 0.83 CACNA1D (0.46) HSD17B10ACHEALDH1A1CYP2C9CYP2C19
SCHEMBL11001264 0.83 CYP2C9 (0.49) HSD17B10ALDH1A1CYP2C9CYP2C19MEN1
SCHEMBL10503447 0.82 DHFR (0.43) DHFRHSD17B10ACHEALDH1A1CYP2C9
SCHEMBL4407407 0.81 PKM (0.56) DHFRHSD17B10ACHEALDH1A1CYP2C9
SCHEMBL10502956 0.81 KDM4E (0.51) HSD17B10ALDH1A1CYP2C9CYP2C19GAA
SCHEMBL9690374 0.80 PKM (0.46) HSD17B10ALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0133530-A2 1,6-Naphthyridinone derivatives, process for their preparation, and medicaments containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1985-02-27 EP disclosed